Arvee Laboratories (India) Ltd.
NSE:ARVEE.NS
173.59 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 303.452 | 612.765 | 396.889 | 471.438 | 448.424 | 539.535 | 447.669 | 344.232 | 268.208 | 129.692 | 117.986 | 34.431 |
| Cost of Revenue
| 202.226 | 439.674 | 258.806 | 328.449 | 323.806 | 432.045 | 343.603 | 238.44 | 169.716 | 75.871 | 75.892 | 28.678 |
| Gross Profit
| 101.226 | 173.091 | 138.083 | 142.989 | 124.618 | 107.49 | 104.066 | 105.792 | 98.492 | 53.821 | 42.094 | 5.753 |
| Gross Profit Ratio
| 0.334 | 0.282 | 0.348 | 0.303 | 0.278 | 0.199 | 0.232 | 0.307 | 0.367 | 0.415 | 0.357 | 0.167 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 14.374 | 10.543 | 27.258 | 7.361 | 6.388 | 10.506 | 1.081 | 0.834 | 0.588 | 0.211 | 0.151 |
| Selling & Marketing Expenses
| 0 | 20.509 | 16.18 | 18.222 | 13.426 | 20.388 | 7.094 | 4.783 | 8.641 | 2.892 | 4.611 | 0.155 |
| SG&A
| 86.239 | 34.883 | 26.723 | 45.48 | 20.787 | 26.776 | 17.599 | 5.864 | 9.475 | 3.48 | 4.822 | 0.306 |
| Other Expenses
| 5.807 | 0.066 | 0.084 | 0.077 | 0.004 | 41.812 | 0.014 | 58.437 | 53.807 | 36.554 | 21.033 | 3.541 |
| Operating Expenses
| 86.239 | 120.694 | 103.99 | 104.913 | 86.249 | 68.588 | 53.552 | 64.301 | 63.282 | 40.034 | 25.855 | 3.847 |
| Operating Income
| 14.987 | 52.016 | 29.936 | 36.623 | 37.323 | 38.239 | 50.514 | 41.491 | 35.21 | 13.787 | 16.239 | 1.906 |
| Operating Income Ratio
| 0.049 | 0.085 | 0.075 | 0.078 | 0.083 | 0.071 | 0.113 | 0.121 | 0.131 | 0.106 | 0.138 | 0.055 |
| Total Other Income Expenses Net
| 3.308 | 9.636 | 4.554 | -0.209 | -6.417 | -12.798 | -31.356 | -32.888 | -29.855 | -23.85 | -16.007 | -1.375 |
| Income Before Tax
| 18.295 | 61.652 | 34.49 | 36.414 | 30.906 | 25.441 | 19.159 | 8.603 | 5.355 | -10.063 | 0.232 | 0.531 |
| Income Before Tax Ratio
| 0.06 | 0.101 | 0.087 | 0.077 | 0.069 | 0.047 | 0.043 | 0.025 | 0.02 | -0.078 | 0.002 | 0.015 |
| Income Tax Expense
| 7.776 | 20.462 | 8.752 | 9.641 | 8.636 | 2.812 | 8.267 | -6.915 | 3.482 | 6.407 | 0.044 | 0.101 |
| Net Income
| 10.518 | 41.19 | 25.738 | 26.774 | 22.99 | 22.629 | 10.891 | 15.518 | 1.874 | -16.47 | 0.188 | 0.43 |
| Net Income Ratio
| 0.035 | 0.067 | 0.065 | 0.057 | 0.051 | 0.042 | 0.024 | 0.045 | 0.007 | -0.127 | 0.002 | 0.012 |
| EPS
| 0.95 | 3.74 | 2.34 | 2.43 | 2.02 | 2.05 | 1.29 | 1.91 | 0.23 | -2.03 | 0.023 | 0.053 |
| EPS Diluted
| 0.95 | 3.74 | 2.34 | 2.43 | 2.02 | 2.05 | 1.29 | 1.91 | 0.23 | -1.49 | 0.023 | 0.053 |
| EBITDA
| 29.969 | 85.608 | 60.095 | 64.725 | 62.306 | 64.612 | 70.635 | 63.171 | 50.761 | 21.072 | 13.963 | 2.888 |
| EBITDA Ratio
| 0.099 | 0.14 | 0.151 | 0.137 | 0.139 | 0.12 | 0.158 | 0.184 | 0.189 | 0.162 | 0.118 | 0.084 |